论文部分内容阅读
目的探讨盐酸氨溴索加连续气道正压通气(CPAP)治疗新生儿呼吸窘迫的临床效果。方法选择78例新生儿呼吸窘迫症患儿,将其随机分为研究组和对照组,每组39例。对照组患儿采用常压吸氧联合盐酸氨溴索治疗,研究组患儿采用盐酸氨溴索加CPAP治疗。治疗后,分析两组患儿时间指标以及临床效果。结果治疗48 h,研究组患儿的氧合指数、p H值优于对照组;治疗3 d,研究组X线评分低于对照组,差异有统计学意义(P<0.05)。研究组时间指标低于对照组,治疗总有效率(92.30%)高于对照组(76.92%),差异有统计学意义(P<0.05)。结论盐酸氨溴索加CPAP机治疗新生儿呼吸窘迫症,可提高治疗总有效率,减少病程。
Objective To investigate the clinical effect of ambroxol hydrochloride plus continuous positive airway pressure (CPAP) on neonatal respiratory distress. Methods 78 neonates with respiratory distress syndrome were selected and randomly divided into study group and control group, 39 cases in each group. Patients in the control group were treated with ambroxol hydrochloride combined with ambroxol hydrochloride. The study group was treated with ambroxol hydrochloride and CPAP. After treatment, analysis of two groups of children with time indicators and clinical effects. Results At 48 hours, the oxygenation index and p H value of the study group were better than those of the control group. The X-ray score of the study group was lower than that of the control group on the 3rd day after treatment (P <0.05). The time of the study group was lower than that of the control group. The total effective rate (92.30%) was higher than that of the control group (76.92%). The difference was statistically significant (P <0.05). Conclusion Ambroxol hydrochloride CPAP machine for neonatal respiratory distress syndrome can improve the total effective rate of treatment and reduce the course of disease.